img click

slideshow

R&D


img Focus Areas
img Pipeline
img Intellectual Property
img Publications

Pipeline


Escape is currently developing several unique and proprietary products that leverage its platform technology, and one additional product that supports it. The below table summarizes each of Escape's products and their respective clinical indications.

Product Description Application(s) Stage
PluraStem™ Universal ESCs1 Pluripotent stem cell line
Preclinical
ImmuStem™ Immune-tolerant adult-derived MSCs Graft-versus-host disease
Preclinical
MesoStem™ Universal adult-derived MSCs1 Type I diabetes
Preclinical
AlloGraf™ Universal living bilayered skin substitute1 Partial thickness wounds
Preclincal
Glucostem™ Universal β cells1 Type I diabetes
Research
MorphoGel™ Biocompatible scaffold1 2-D stem cell culture
3-D stem cell culture
Scaffold for artificial skin
Pre-launch
Pre-launch
Preclinical
FibroStem™ Universal fibroblasts Skin atrophy, scars
Preclinical
Neurox™ Muscle paralytic Spasticity
Wrinkles
Preclincal
Clinical2
OsteoStem™ Osteogenic progenitor cells1 Acute fractures
Preclinical
1contains Escape's platform IT™ technology
2a 15-patient pilot clinical study was completed and results published

2010 Escape Therapeutics, Inc. All rights reserved.

Website design by Sylvia Do & Chris Nye

img